Back to search

West Virginia University

Burkholderia Collagen-Like Protein 8, Bucl8, Is an Outer-Membrane Component of a Novel Efflux Pump and Immunogenic Vaccine Candidate

Abstract

dc:description.abstract

Burkholderia spp. are Gram‐negative intrinsically resistant bacteria that are responsible for environmental and nosocomial infections of clinical and biodefense concern. Our laboratory previously identified in silico Burkholderia collagen-like protein 8 (Bucl8) in the BSL-3 pathogens Burkholderia pseudomallei and Burkholderia mallei (Figure 1). The protein sequence of Bucl8 contains tandem outer-membrane efflux protein domains (OEP) typical of efflux systems and a unique collagen-like domain (CL) consisting of a repeating sequence of Glycine-Alanine-Serine (GAS). Because efflux pumps are often a mechanism of pathogenicity and antibiotic resistance, we investigated Bucl8 further. Here, we determined that the locus of bucl8 contains genes encoding a novel tripartite efflux pump that confers resistance to fusaric acid and pHBA, but not clinically-relevant antibiotics. Furthermore, deletion of the pump resulted delayed growth, suggesting a physiological role of the pump in human infectious strains. In addition to the prototypical barrel of outer membrane efflux proteins, Bucl8 has an extracellular GAS(n)-CL domain that forms a triple helix and binds fibrinogen. Moreover, we developed Burkholderia vaccine formulations based on the predicted immunogenic eipitopes of Bucl8, including the conserved, surface-exposed loops, L1 and L2, and portions of the collagen-like and C-terminal domains. Several combinations with different antigens, adjuvants, peptide conjugates, and routes of administration were tested for immunogenicity and/or protection in an intranasal challenge model utilizing outbred CD-1 mice and BSL-2 surrogate, B. thailandensis. The combination that reduced inflammation and disease the most was an intranasally administrated formulation of synthetic peptide of L1 conjugated to cross-reacting material 197 (CRM197) and adjuvanted with fluorinated cyclic diguanylate monophosphate (FCDG). Correlating disease outcomes with IgG antibody subtypes, T helper cell cytokines, and different myeloid cells, we determined that IL-10 correlated with morbidity, IgG2a with improved outcomes, and vaccination with reduced TH1/TH17 tissue-damaging cytokines. These humoral and cell-mediated correlates of protection could be used as biomarkers for diseases or applied to other therapeutics.

Degree

thesis:*
Name thesis:degree_name
PhD
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Microbiology, Immunology, and Cell Biology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Grund, Megan Elizabeth
Contributors dc:contributor
  • Slawomir Lukomksi
  • Mariette Barbier
  • Jennifer Franko
  • Paul LaSala
  • Karen Martin

Subjects

dc:subject × 13

Identifiers

dc:identifier.*
Identifier
<p><a href="https://orcid.org/0000-0003-4103-3151">https://orcid.org/0000-0003-4103-3151</a></p>
https://researchrepository.wvu.edu/etd/11659

Chain of custody

source
Harvested from
West Virginia University
Base URL
researchrepository.wvu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Grund, Megan Elizabeth. Burkholderia Collagen-Like Protein 8, Bucl8, Is an Outer-Membrane Component of a Novel Efflux Pump and Immunogenic Vaccine Candidate. Dissertation thesis, https://doi.org/10.33915/etd.11659